Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yinqu Capsule in Dyslipidemia (Phase II)
CTR20132368Phase 2Completed
- Sponsor
- Nanjing Hailing Pharmaceutical
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rosuvastatin in dyslipidemia, sponsored by Nanjing Hailing Pharmaceutical. Started Jan 2014; status: completed.
02
Drugs
rosuvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on CTR20132368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132368.